Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

Clinical trial NCT01275677 · COMPLETED

Trial details

NCT number: NCT01275677
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HER2/Neu Positive Progesterone Receptor Positive Recurrent Breast Carcinoma Stage IA Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7

Start date: 2011-02-08
Primary completion: 2017-07-31
Enrollment: 3270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.